Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

Articles

Now expected to obtain its production license during the next few days, an H1N1 vaccine developed by Sinovac Biotech (China) has passed the experts' evaluation by the Chinese State Food and Drug Administration (SFDA).

One-shot H1N1 vaccine gets Chinese thumbs up

An H1N1 vaccine developed by biopharmaceutical company Sinovac Biotech (Beijing, China) has passed the experts evaluation organized by the Chinese State Food and Drug Administration (SFDA) and the company is expected to obtain a production license before the week's end.

One-Shot H1N1 Vaccine Gets Chinese Thumbs Up

The author describes the approach taken to develop a facility dedicated to handling potent and cytotoxic drug substances.

Design and Construction of a Potent Pharmaceutical CGMP Suite

The author reviews the major biopharmaceutical markets' activity and predicts how the markets may evolve.

Market Outlook for Biosimilars

The authors describe the various available technologies used in orally disintegrating tablets.

Orally Disintegrating Tablets: The Effect of Recent FDA Guidance on ODT Technologies and Applications

Paul Nelles is Vice President Development Services at Vetter Pharma-Fertigung GmbH & Co. KG (Germany).

Why correctly calibrating a drug with its packaging is the key to success.

Successful packaging of aseptically prefilled products

The Czech Republic will no longer purchase the H1N1 flu vaccine from Baxter International.

Czech's reject Baxter flu vaccine

Scientists have modified a tobacco plant to produce a vaccine for norovirus, the viral infection sometimes referred to as the "cruise ship virus".

Tobacco plant helps produce norovirus vaccine

Scientists have modified a tobacco plant to produce a vaccine for norovirus, the viral infection sometimes called the "cruise ship virus."